4//SEC Filing
Bush Tia L 4
Accession 0001470831-25-000343
CIK 0001847903other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:17 PM ET
Size
8.9 KB
Accession
0001470831-25-000343
Insider Transaction Report
Form 4
Bush Tia L
Chief Technology & Quality Ofc
Transactions
- Exercise/Conversion
Share Option (right to buy)
2025-11-17−40,000→ 360,338 totalExercise: $9.42Exp: 2031-05-07→ Ordinary Shares (40,000 underlying) - Sale
Ordinary Shares
2025-11-17$28.00/sh−40,000$1,120,000→ 121,503 total - Exercise/Conversion
Ordinary Shares
2025-11-17$9.42/sh+40,000$376,800→ 161,503 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 14, 2024.
- [F3]25% of the shares subject to such option shall vest and become exercisable on May 20, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001863418
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:17 PM ET
- Size
- 8.9 KB